Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:XENT Intersect ENT (XENT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Intersect ENT Stock (NASDAQ:XENT) 30 days 90 days 365 days Advanced Chart Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Intersect ENT alerts:Sign Up Key Stats Today's Range$28.24▼$28.2450-Day Range$28.24▼$28.2452-Week Range$15.92▼$28.25Volume14,512 shsAverage Volume351,526 shsMarket Capitalization$954.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIntersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.Read More… 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Receive XENT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intersect ENT and its competitors with MarketBeat's FREE daily newsletter. Email Address XENT Stock News HeadlinesKiatnakin Bank PCL (KKP)July 26, 2024 | investing.comXENT Historical DataOctober 21, 2023 | investing.comCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!November 2, 2024 | Crypto 101 Media (Ad)Music At The Intersection Festival Tells St. Louis’ Rich Musical HistorySeptember 12, 2023 | yahoo.comCruise car reportedly swerves in backhoe's way, is busted in SF intersectionAugust 28, 2023 | sfgate.comWoman ejected from car after being hit by driver doing donuts in Long Beach intersectionJune 24, 2023 | cbsnews.comDrivers shut down Alexander County intersection during unsanctioned street takeoverFebruary 22, 2023 | news.yahoo.com4 levels of living space and a garage in D.C. Shaw’s neighborhoodFebruary 18, 2023 | washingtonpost.comSee More Headlines XENT Stock Analysis - Frequently Asked Questions How were Intersect ENT's earnings last quarter? Intersect ENT, Inc. (NASDAQ:XENT) posted its quarterly earnings results on Tuesday, November, 2nd. The medical equipment provider reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.42) by $0.06. The medical equipment provider earned $24.40 million during the quarter, compared to analysts' expectations of $29.63 million. Intersect ENT had a negative net margin of 161.94% and a negative trailing twelve-month return on equity of 709.52%. What other stocks do shareholders of Intersect ENT own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intersect ENT investors own include SEASPAN CORP/SH SH (SSW), Textainer Group (TGH), iShares MSCI Brazil ETF (EWZ), Costamare (CMRE), Mimecast (MIME), EOG Resources (EOG) and Air Transport Services Group (ATSG). Company Calendar Last Earnings11/02/2021Today11/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:XENT CUSIPN/A CIK1271214 Webwww.intersectent.com Phone(650) 641-2100Fax866-736-1251Employees433Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-159,630,000.00 Net Margins-161.94% Pretax Margin-163.16% Return on Equity-709.52% Return on Assets-48.18% Debt Debt-to-Equity Ratio6.89 Current Ratio1.88 Quick Ratio1.50 Sales & Book Value Annual Sales$106.75 million Price / Sales8.95 Cash FlowN/A Price / Cash FlowN/A Book Value($2.06) per share Price / Book-13.71Miscellaneous Outstanding Shares33,814,000Free Float33,104,000Market Cap$954.91 million OptionableOptionable Beta1.45 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:XENT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intersect ENT, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intersect ENT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.